October 19, 2010 – A new high-definition (HD) technology reduces blur created by respiration during positron emission tomography/computed tomography (PET/CT) studies. The Siemens HD Chest provides full HD lesion detection and improved standardized uptake value (SUV) quantification.

The technology was announced earlier this month at the European Association of Nuclear Medicine congress in Vienna, Austria.

By providing a highly automated, amplitude-based gating technology, HD Chest images the chest and upper abdomen in high definition and eliminates the fundamental problems encountered with phase-based 4-D gating, which can be disruptive and time consuming.

Because breathing motion is chaotic, the direction of motion and its magnitude vary from patient to patient. They also vary from session to session for a given patient, and even from moment to moment within the procedure. HD Chest optimizes each patient’s respiratory curve to automatically produce the highest quality PET image. It intelligently adapts to every patients breathing and automatically selects the optimal data range with the least amount of motion and the highest count statistics.

For more information: www.siemens.com/healthcare


Related Content

News | Radiopharmaceuticals and Tracers

Nov. 11, 2025 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has released a position paper outlining ...

Time November 12, 2025
arrow
News | FDA

Oct. 30, 2025 — Sirona Medical has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Sirona ...

Time October 30, 2025
arrow
News | Prostate Cancer

Aug. 13, 2025 — A new study from Denmark shows for the first time that men with biochemically recurrent prostate cancer ...

Time August 15, 2025
arrow
News | Mammography

Aug. 5, 2025 — New Lantern has announced the launch of two specialized viewer modes: the Mammography Viewer Mode and PET ...

Time August 05, 2025
arrow
News | Nuclear Imaging

May 5, 2025 — GE HealthCare recently announced that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance ...

Time May 06, 2025
arrow
News | Prostate Cancer

July 30, 2024 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization ...

Time July 30, 2024
arrow
News | Radiopharmaceuticals and Tracers

July 25, 2024 — NorthStar Medical Radioisotopes, LLC and BWXT Medical Ltd., a subsidiary of BWX Technologies, Inc ...

Time July 25, 2024
arrow
News | PET-CT

July 25, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET & PET-CT imaging ...

Time July 25, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | ASTRO

June 21, 2024 — The American Society for Radiation Oncology (ASTRO) announced today that following a nationwide search ...

Time June 21, 2024
arrow
Subscribe Now